Hubei Goto Biopharm Co.,Ltd. (300966.SZ) SHZ

20.61

-0.07(-0.34%)

Updated at December 05 12:04PM

Currency In CNY

Valuation

Market Cap1.86B
Enterprise Value2.83B
P/E Ratio-51.89
PEG Ratio1.56
Price/Sales Ratio3.81
Price/Book Ratio2.73
Enterprise/Revenue5.74
Enterprise/EBITDA-274.97

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.07
Operating Margin-0.09

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.05

Income Statement

Revenue536.6M
Revenue/Share5.44
Gross Profit105.56M
EBITDA21.23M
Net Income-27.59M
Diluted EPS-0.24

Balance Sheet

Total Cash94.66M
Total Cash/Share0.82
Total Debt1.3B
Total Debt/Equity1.5
Current Ratio1.02
Book Value Per Share8.32

Price History

52-Week Change11.66
52-Week High29.77
52-Week Low13.04
Moving Average 50 Days22.11
Moving Average 200 Days19.72

Statistics

Average Volume2.58M
Shares Outstanding115.28M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.49
Last Split FactorN/A
Last Split DateN/A